SCHEMBL420333

SCHEMBL420333

CC(=O)OC(CCC(N)=O)C(C)N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.41
ALOX15 P16050 1/20 0.41
PMP22 Q01453 1/20 0.41
KMT2A Q03164 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
TSHR P16473 2/20 0.38
DPP4 P27487 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP9 Q86TI2 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
TBXA2R P21731 1/20 0.34
GABRP O00591 2/20 0.33
GABRD O14764 2/20 0.33
GABRA1 P14867 2/20 0.33
GABRB1 P18505 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419537 0.83 ALOX15 (0.39) BLMALOX15PMP22KMT2ATRPV1
SCHEMBL420604 0.80 TSHR (0.41) BLMALOX15KMT2ATRPV1TSHR
SCHEMBL421702 0.78 TRPV1 (0.41) BLMALOX15TRPV1TSHRTDP1
SCHEMBL422004 0.78 TRPV1 (0.38) TRPV1TSHRTDP1CHRM2CHRM4
SCHEMBL420644 0.77 TRPV1 (0.47) BLMTRPV1TSHRDPP4DPP8
SCHEMBL421635 0.76 TRPV1 (0.39) BLMTRPV1TSHRTDP1CHRM2
SCHEMBL420341 0.76 TRPV1 (0.50) TRPV1TSHRTDP1CHRM2CHRM4
SCHEMBL421642 0.75 TSHR (0.44) BLMALOX15TRPV1TSHRTDP1
SCHEMBL420619 0.75 TSHR (0.44) BLMTRPV1TSHRTDP1CHRM2
SCHEMBL14396088 0.74 TRPV1 (0.53) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120060856-A1 Cosmetic Composition and Reshaping Method for Keratinic Fibers HENKEL AG & CO. KGAA (DE) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120060856-A1 Cosmetic Composition and Reshaping Method for Keratinic Fibers H1-0, H1-3, H1-2 BLM 1580/4885ALOX15 4521/4885PMP22 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.